Inventor · disambiguated record
Dana Larocca
Also filed as: LAROCCA DANA
5 granted patents·12 pending applications·20 citations·filing 2015–2024
76Inventor score
Files withAGEX THERAPEUTICS INC7RECYTE THERAPEUTICS INC5MANDALA BIOSCIENCES LLC2BIOTIME INC1FURTHER BIOTECHNOLOGIES LLC1
Top patents by PatentIndex Score
17 records- 0190US10240127B2Exosomes from clonal progenitor cellsRECYTE THERAPEUTICS INC·Filed 2015·Granted Mar 26, 2019·11 cites·20 claims
- 0286US10227561B2Methods and compositions for targeting progenitor cell linesMANDALA BIOSCIENCES LLC·Filed 2015·Granted Mar 12, 2019·6 cites·7 claims
- 0380US11274281B2Exosomes from clonal progenitor cellsRECYTE THERAPEUTICS INC·Filed 2019·Granted Mar 15, 2022·1 cites·20 claims
- 0480US2024384240A1SUPERCENTENARIAN INDUCED PLURIPOTENT STEM (sciPS) CELLS AND METHODS OF MAKING AND USING THEREOFFURTHER BIOTECHNOLOGIES LLC·Filed 2024·Application pending·0 cites
- 0572US11078462B2Perivascular stromal cells from primate pluripotent stem cellsRECYTE THERAPEUTICS INC·Filed 2015·Granted Aug 3, 2021·2 cites·8 claims
- 0672US2022160833A1Methods for detecting and modulating the embryonic-fetal transition in mammalian speciesAGEX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0772US2022088137A1Methods for detecting and modulating the embryonic-fetal transition in mammalian speciesAGEX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0871US2022088138A1Methods for detecting and modulating the embryonic-fetal transition in mammalian speciesAGEX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0967US2022403341A1Exosomes from clonal progenitor cellsRECYTE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1064US11981930B2Supercentenarian induced pluripotent stem (sciPS) cells and methods of making and using thereofLAROCCA DANA·Filed 2020·Granted May 14, 2024·0 cites·19 claims
- 1160US2019175691A1Methods for detecting and modulating the embryonic-fetal transition in mammalian speciesBIOTIME INC·Filed 2018·Application pending·0 cites
- 1258US2022401494A1Pericyte cell exosomesAGEX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1356US2019218511A1Methods and compositions for targeting progenitor cell linesMANDALA BIOSCIENCES LLC·Filed 2019·Application pending·0 cites
- 1455US2022098554A1Perivascular stromal cells from primate pluripotent stem cellsRECYTE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1552US2021338822A1Therapeutic exosomes and method of producing themAGEX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1647US2020306296A1Induced tissue regeneration using extracellular vesiclesAGEX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1747US2019151372A1Pericyte cell exosomesAGEX THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →